Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Upsala Journal of Medical Sciences|March 15, 2018
The effect of the first-generation HCV-protease inhibitors boceprevir and telaprevir and the relation to baseline NS3 resistance mutations in genotype 1: experience from a small Swedish cohortMidori Kjellin, Terése Wesslén, Erik Löfblad, et al.The Journal of General Virology|January 25, 2006
Influence of naturally occurring insertions in the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase on polymerase fidelity and mutation frequencies in vitroKenneth Curr, Snehlata Tripathi, Johan Lennerstrand, et al.Journal of Virology|March 1, 2003
Effects of dipeptide insertions between codons 69 and 70 of human immunodeficiency virus type 1 reverse transcriptase on primer unblocking, deoxynucleoside triphosphate inhibition, and DNA chain elongationPeter R Meyer, Johan Lennerstrand, Suzanne E Matsuura, et al.Infectious Diseases (London, England)|April 9, 2015
Prevalence of polymorphisms with significant resistance to NS5A inhibitors in treatment-naive patients with hepatitis C virus genotypes 1a and 3a in SwedenIda Lindström, Midori Kjellin, Navaneethan Palanisamy, et al.Virology Journal|October 18, 2022
SARS-CoV-2 variants of concern and spike protein mutational dynamics in a Swedish cohort during 2021, studied by Nanopore sequencingSteinar Mannsverk, Julia Bergholm, Navaneethan Palanisamy, et al.Journal of Biomolecular Structure & Dynamics|December 28, 2019
Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 proteaseDario Akaberi, Praveen K Chinthakindi, Amanda Båhlström, et al.Antiviral Therapy|May 11, 2018
Worldwide prevalence of baseline resistance-associated polymorphisms and resistance mutations in HCV against current direct-acting antiviralsNavaneethan Palanisamy, Prabhav Kalaghatgi, Dario Akaberi, et al.Infection Ecology & Epidemiology|January 24, 2014
Transmission of hepatitis C virus among intravenous drug users in the Uppsala region of SwedenAxel Danielsson, Navaneethan Palanisamy, Sultan Golbob, et al.AIDS (London, England)|June 26, 2003
Use of HIV-1 reverse transcriptase recovered from human plasma for phenotypic drug susceptibility testingXing-Wu Shao, Anders Malmsten, Johan Lennerstrand, et al.Redox Biology|October 2, 2020
Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitroDario Akaberi, Janina Krambrich, Jiaxin Ling, et al.Pageof 4